FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to a new cyclic peptide compound or its pharmaceutically acceptable salt which shows a hepatitis C virus activity based on an inhibiting activity of RNA replication of a hepatitis C virus replicon, to a method of producing it involving regrouping in a soft acid medium followed by amino acid exchange reactions, to a pharmaceutical composition containing said compound.
EFFECT: preparation of the drug exhibiting the anti-HCV activity.
16 cl, 44 tbl, 228 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVE OF DI- AND TRIAZOLYLPROPANE, METHODS OF ITS SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1996 |
|
RU2145605C1 |
DERIVATIVES OF AZOLE, METHODS OF THEIR SYNTHESIS AND ANTIFUNGAL AGENT | 1994 |
|
RU2131417C1 |
DERIVATIVES OF CYCLOHEXANE OR TETRAHYDROPYRANE OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, OR HYDRATES, OR SOLVATES OF THESE COMPOUNDS, OR THEIR SALTS, INTERMEDIATE COMPOUNDS FOR THEIR SYNTHESIS AND FUNGICIDE AGENT | 1992 |
|
RU2084439C1 |
α-PHENYL- OR PYRIDYLETHANOLAMINES AND THEIR USING AS β DRENOCEPTOR AGONISTS | 2003 |
|
RU2319698C2 |
NEW BENZOAZEPINE DERIVATIVE AND ITS MEDICAL APPLICATION | 2013 |
|
RU2642783C2 |
DERIVATIVES OF NAPHTHALENE, PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2155188C2 |
DERIVATIVES OF AZOLE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1993 |
|
RU2116304C1 |
DERIVATIVES OF CARBAPENEM, THEIR USING FOR PREPARING PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR TREATMENT AND/OR PROPHYLAXIS OF INFECTIOUS DISEASES | 2001 |
|
RU2276154C2 |
THIAZOLE DERIVATIVES | 2005 |
|
RU2367661C2 |
PYRROLOPYRAZINE DERIVATIVES, PHARMACEUTICAL COMPOSITION, METHOD FOR PREVENTION AND TREATMENT OF DISEASES, APPLICATION AS PHOSPHODIESTERASE IV AND/OR TUMOR NECROSIS FACTOR PRODUCTION INHIBITOR | 2003 |
|
RU2328499C2 |
Authors
Dates
2011-07-10—Published
2006-10-26—Filed